Literature DB >> 378837

Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans.

P B Helstrom, E Balish.   

Abstract

Scanning electron microscopy, light microscopy, and quantitative culture of microorganisms in intestinal contents were used to determine the effects of oral tetracycline, the bacterial flora of conventionally reared animals (conventional), and thymus-dependent immune competency on the capacity of Candida albicans to colonize and infect the gastrointestinal tract of four groups of mice: thymus-intact conventional mice, conventional athymic mice, flora-defined athymic mice, and thymus-intact bacteria-free mice. Thymus-intact conventional mice without antibiotic treatment began to shed C. albicans less than 48 h after oral yeast challenge and were devoid of detectable yeast by day 16. Tetracycline altered the bacterial flora qualitatively and quantitatively, allowing C. albicans to colonize in less than 48 h and to persist in the gut tract for 32 days. Only 2 of 72 of these conventional mice developed candidiasis (hyphal infection). Although tetracycline altered the bacterial flora of conventional athymic (nude) mice, it was not required to allow C. albicans to colonize their gut tract to levels significantly higher than those in thymus-intact conventional mice. All conventional nude mice were consistently colonized and 14 of 24 animals showed an increased yeast colonization of the keratinized stomach, but only 3 of 24 developed gastric candidiasis. Flora-defined athymic (nude) mice had significantly lower aerobic bacterial levels and significantly higher C. albicans levels in the gut contents than conventional athymic mice. The flora-defined nude mice, however, developed gastric candidiasis by day 5. Thymus-intact bacteria-free mice were uniformly colonized and infected with C. albicans less than 48 h after oral challenge regardless of tetracycline treatment. Populations of C. albicans in the gut of bacteria-free mice were significantly higher than in the gut tract of the thymus-intact conventional or athymic mice. Gastric mycelial infection was detected in 8 of 10 bacteria-free animals 2 days after oral challenge. By 32 days, 45 of 50 mice of both tetracycline-treated and control bacteria-free groups were infected with C. albicans. These data indicate that a competive bacteria flora is more effective than an intact immune system in preventing gastric candidiasis and that an immune deficiency may allow increased yeast colonization of the keratinized and glandular stomach epithelium. Tetracycline did not appear to enhance the invasiveness or pathogenicity of C. albicans in mice even though it facilitates yeast-phase gut colonization in conventionally reared mice.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378837      PMCID: PMC414232          DOI: 10.1128/iai.23.3.764-774.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  The biology of experimental human cutaneous moniliasis (Candida albicans).

Authors:  H I MAIBACH; A M KLIGMAN
Journal:  Arch Dermatol       Date:  1962-02

2.  The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis.

Authors:  T J Rogers; E Balish; D D Manning
Journal:  J Reticuloendothel Soc       Date:  1976-10

3.  Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice.

Authors:  J E Cutler
Journal:  J Reticuloendothel Soc       Date:  1976-02

4.  Inhibition of Candida albicans by Escherichia coli in vitro and in the germfree mouse.

Authors:  R P Hummel; E J Oestreicher; M P Maley; B G Macmillan
Journal:  J Surg Res       Date:  1973-07       Impact factor: 2.192

5.  Effects of oral inoculation of Candida albicans in tetracycline-treated rats.

Authors:  C Russell; J H Jones
Journal:  J Med Microbiol       Date:  1973-08       Impact factor: 2.472

6.  Gastrointestinal microecology of BALB/c nude mice.

Authors:  J F Brown; E Balish
Journal:  Appl Environ Microbiol       Date:  1978-07       Impact factor: 4.792

7.  Gastrointestinal candidiasis in rats treated with antibiotics, cortisone, and azathioprine.

Authors:  A DeMaria; H Buckley; F von Lichtenberg
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

8.  Growth, morphogenesis, and virulence of Candida albicans after oral inoculation in the germ-free and conventional chick.

Authors:  E Balish; A W Phillips
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

9.  Chemotactic factor produced by Candida albicans.

Authors:  J E Cutler
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Preservation of gastrointestinal bacteria and their microenvironmental associations in rats by freezing.

Authors:  C P Davis
Journal:  Appl Environ Microbiol       Date:  1976-02       Impact factor: 4.792

View more
  35 in total

1.  Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Authors:  T J Walsh; P A Pizzo
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome.

Authors:  R Narayanan; W A Joyce; R A Greenfield
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 3.  Murine models of Candida gastrointestinal colonization and dissemination.

Authors:  Andrew Y Koh
Journal:  Eukaryot Cell       Date:  2013-09-13

Review 4.  Inflammation and gastrointestinal Candida colonization.

Authors:  Carol A Kumamoto
Journal:  Curr Opin Microbiol       Date:  2011-07-28       Impact factor: 7.934

5.  Esophageal Candida infection and adherence mechanisms in the nonimmunocompromised rabbit.

Authors:  K Hoshika; M Iida; H Mine
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

6.  Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism.

Authors:  M J Kennedy; P A Volz
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Mice with persistent gastrointestinal Candida albicans as a model for antifungal therapy.

Authors:  C Herrera; M N Guentzel
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

8.  Colonization of congenitally athymic, gnotobiotic mice by Candida albicans.

Authors:  E Balish; M J Balish; C A Salkowski; K W Lee; K F Bartizal
Journal:  Appl Environ Microbiol       Date:  1984-04       Impact factor: 4.792

Review 9.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

10.  Gastric colonization with Candida albicans.

Authors:  R A Greenfield; W A Joyce
Journal:  Mycopathologia       Date:  1993-04       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.